Arimidex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Fluzoparib;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: Tamoxifen;   Drug: Toremifene;   Drug: Abemaciclib;   Drug: LHRH agonist Sponsor:   Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Conditions:   Breast Cancer;   Cancer of the Breast Interventions:   Device: VENTANA MIB-1 Ki67 assay;   Device: Oncotype DX® Recurrence Score;   Device: PAM50-based Prosigna breast cancer gene signature assay;   Drug: Anastrozole;   Drug: Combination anthracycline and/or taxane based treatment Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2023 Category: Research Source Type: clinical trials